CPB (CPF)
(Delayed Data from NYSE)
$28.32 USD
-0.69 (-2.38%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $28.34 +0.02 (0.07%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for CPB Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 329 | 281 | 262 | 258 | 258 |
Cost Of Goods | 63 | 11 | 4 | 10 | 24 |
Gross Profit | 266 | 269 | 258 | 247 | 234 |
Selling & Adminstrative & Depr. & Amort Expenses | 180 | 165 | 148 | 194 | 148 |
Income After Depreciation & Amortization | 87 | 105 | 110 | 53 | 86 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 10 | 6 | 4 | 4 | 8 |
Pretax Income | 77 | 99 | 106 | 49 | 78 |
Income Taxes | 18 | 25 | 26 | 12 | 20 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 59 | 74 | 80 | 37 | 58 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 59 | 74 | 80 | 37 | 58 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 97 | 117 | 129 | 76 | 104 |
Depreciation & Amortization (Cash Flow) | 11 | 13 | 20 | 22 | 18 |
Income After Depreciation & Amortization | 87 | 105 | 110 | 53 | 86 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 27.08 | 27.57 | 28.26 | 28.18 | 28.68 |
Diluted EPS Before Non-Recurring Items | 2.17 | 2.68 | 2.83 | 1.32 | 2.03 |
Diluted Net EPS (GAAP) | 2.17 | 2.68 | 2.83 | 1.32 | 2.03 |
Fiscal Year end for CPB Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 87.96 | 85.65 | 89.29 | 82.46 | 79.76 |
Cost Of Goods | 21.64 | 21.93 | 20.67 | 18.19 | 14.01 |
Gross Profit | 66.32 | 63.71 | 68.62 | 64.27 | 65.75 |
SG&A, R&D, and Dept/Amort Expenses | 43.39 | 44.51 | 47.18 | 44.49 | 44.22 |
Income After SG&A, R&D, and Dept/Amort Expenses | 22.93 | 19.20 | 21.44 | 19.78 | 21.53 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.28 | 2.28 | 2.30 | 2.29 | 2.58 |
Pretax Income | 20.65 | 16.92 | 19.14 | 17.49 | 18.95 |
Income Taxes | 4.84 | 3.97 | 4.27 | 4.35 | 4.47 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 15.82 | 12.95 | 14.87 | 13.14 | 14.48 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 15.82 | 12.95 | 14.87 | 13.14 | 14.48 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 27.12 | 27.10 | 27.10 | 27.08 | 27.07 |
Diluted EPS Before Non-Recurring Items | 0.58 | 0.48 | 0.55 | 0.49 | 0.53 |
Diluted Net EPS (GAAP) | 0.58 | 0.48 | 0.55 | 0.49 | 0.53 |